Changes in desire, sexual function, energy or mood are common, and they’re often connected to hormones, sleep, stress, medications or heart health. A licensed medical provider reviews your history privately before discussing whether a compounded protocol is appropriate for you.
Adults noticing changes in libido, sexual function, or energy and mood that may be hormone-related, who want a discreet, provider-led look at what’s going on.
PT-141, which acts on pathways in the brain related to sexual desire. CJC-1295 / Ipamorelin and Tesamorelin act on growth hormone signaling. Your provider decides whether any protocol is appropriate, and may ask for lab work first.
New erectile difficulties, especially alongside chest pain, shortness of breath or other heart symptoms, should be evaluated in person, since they can be an early sign of heart disease. So should pelvic pain, unexpected bleeding, or changes that began after starting a new medication. Your provider will tell you when in-person care is the right first step.
Yes. Your intake and messages are visible only to you and your care team, and approved orders are shipped discreetly.
No. An FDA-approved bremelanotide product exists for one specific use. Compounded PT-141 is prepared for an individual patient by a compounding pharmacy and is not FDA-approved.
Your provider may ask for recent lab work, including hormone levels, before deciding whether any protocol is appropriate.